maxFRC in Infancy
A Multicenter Collaborative Study |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Measurements of maximal flow at functional residual capacity
(
max FRC) from partial forced expiratory maneuvers remain the most popular method for assessing small airway function in infants and young children. However, the lack of appropriate reference data that are both applicable outside the centers that developed them and reflect the normal variability between healthy
subjects has limited interpretation of
max FRC results in both clinical practice and research. To address this problem, we collated
max FRC data from 459 healthy infants (226 boys) tested on 654 occasions during the first 20 months of life from three collaborating centers. Multiple linear regression analysis indicated that sex,
age, and length were important predictors of
max FRC, which was,
on average, 20% higher in girls than in boys during the first 9 months of life. (
max FRC)0.5 (ml · second
1) = 4.22 + 0.00210 × length2 (cm) for boys (RSD = 3.01; R2 = 0.48), and
1.23 + 0.242 × length for girls (RSD = 2.72; R2 = 0.49). Alternative models incorporating both age and length z scores are also described. Failure
to use sex-specific prediction equations for
max FRC may preclude
detection of clinically significant changes in girls and lead to false
reports of diminished airway function in boys. Appropriate use of
z scores, which indicate a "normal" range (z scores of 0 ± 2) for
max FRC, during infancy should also improve interpretation of both
clinical and research studies.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: forced expiratory flow; infant; reference values; respiratory function tests; sex
Despite the introduction of the raised volume technique for
assessing full forced expiratory maneuvers in infants (1-5), the
measurement of maximal flow at functional residual capacity (
maxFRC) by the tidal rapid thoracoabdominal compression
technique remains the most popular method of assessing small
airway function in infants and young children (4, 6-8). One of
the advantages of this technique is that it has been used in a
large number of physiologic, clinical, and epidemiological
investigations to assess the early determinants of airway function (9-14); investigate airway responsiveness in infants (15-
20); examine diseases such as cystic fibrosis (18, 21-23), bronchiolitis (24, 25), and bronchopulmonary dysplasia (26); and
evaluate the impact of treatment strategies (22, 27-30) or antecedent respiratory illness on subsequent airway function (11,
31-34).
Nonetheless, interpretation of
maxFRC measurements in
both clinical practice and research has been limited by a lack
of appropriate reference data that are applicable outside the
centers that developed them. Indeed, despite considerable advances in standardizing equipment and techniques for assessing
lung function in infants (35, 36), reliable normative reference
data remain limited. This can be ascribed to the time-consuming
nature of these tests and the need for sedation in all but the
youngest infants. Although there have been several attempts to
report normative data for
maxFRC (14, 37-40), the relatively
small size of most of these studies makes characterization of even
the most basic influences on airway growth, such as age, sex, and
size, difficult to describe reliably (41, 42). Difficulties in generalizing such results are compounded when they are used elsewhere to interpret results from populations with different
background characteristics and/or where measurements have
been obtained by using different instruments or protocols. A
further problem is the use of "percent predicted" to express
results, as this does not take into account the natural variability
of
maxFRC between subjects of similar age or body size (43).
The current investigation attempts to address this deficiency of normative reference data by combining
maxFRC results from four studies performed in three centers on two continents. It includes data from four published studies (9, 14, 38, 44).
The aim of this study was to combine existing data for
maxFRC in healthy infants measured during the first 2 years
of life, to develop more robust and generalizable reference
data and prediction equations that could be expressed as z scores
after taking sex, age, and body size into account.
| |
METHODS |
|---|
|
|
|---|
maxFRC and background details including sex, age, weight, and
length at test from all individual infants were collated from the three
participating centers (London, Indianapolis, and Boston) (9, 10, 14,
38, 44). These centers were known to have used similar equipment
and methodology and to have applied similar criteria regarding technical acceptability of results. The London center (Institute of Child
Health) provided data from two groups of infants, one recruited as
part of a study investigating the effects of maternal smoking (9) and
ethnicity (10) on lung function in preterm infants (hereafter referred
to as London preterm infants), and the other recruited to a study of
the influence of low birth weight for gestational age on airway function in full-term infants (London term infants) (44). As summarized in
Table 1, ethnic composition varied by center. Of the 92 London preterm infants, 48 were white (46% boys) and 38 were black (53% boys),
whereas all the London term infants were white, of whom 46% were
boys. Of the 153 infants in the Boston study, 62 were white (45%
boys) and 83 were Hispanic (43% boys). Only limited individual data
were stored long term from the Indianapolis study, but details in the
original publication and communication with the authors confirmed
that ~ 85% of these infants were white and 56% were boys (14).
|
Cross-sectional
maxFRC data were obtained from the London
preterm infants at 3 weeks corrected postnatal age (i.e., age after the
expected rather than actual date of delivery, where expected dates
were based on ultrasonic assessments before 20 weeks of gestation),
whereas the initial measurements of the London term infants were
performed between 1 and 3 months corrected postnatal age, with
measurements being repeated in a subset of the sample at 7
10
months of age. Of the 110 London term infants, repeat measurements
were available on two occasions for 28 infants and on three occasions
for 3 infants. Both American studies were based primarily on term infants. Data from Indianapolis were from a cross-sectional study aiming to extend the age range of normative data for
maxFRC and lung
volume in infants (14), whereas data from Boston were obtained as
part of a longitudinal investigation of the impact of prenatal cigarette
smoke exposure on lung function in infancy (13, 31). Additional
maxFRC values from 50 Boston infants and six Indianapolis infants
that had not been included in previous publications were available for
the current collated data set. In the Boston study, lung function tests
were performed during four discrete age intervals after birth, namely
2
6 weeks, and then 4
6, 10
12, and 15
18 months of age. Seventy-eight of the 153 Boston infants were studied twice, 46 were studied
three times, and 28 were studied on four occasions; the remaining infants were studied only once.
Details of study design and methods of measuring
maxFRC within
each center have been reported previously (9, 10, 14, 38, 44) and are
summarized in Table 2. The mean
maxFRC, derived from the three
technically satisfactory maneuvers with the highest forced expiratory
flows at FRC, was used to calculate the prediction equations. Results
from these three maneuvers were generally within 10% of each other
(for details see online data supplement).
|
Description of the Representative Data Set
maxFRC values for 514 infants measured on 719 occasions were compiled from the four studies. To ensure that the final data set was representative of normal infants and that sufficient infants were included
from multiple centers across the entire age/length range studied, two
major exclusions were necessary. First, only 14 infants had been measured beyond 20 months of age, and all of these infants had been studied in Indianapolis. Results from these tests were excluded. Second,
the London term study had been designed to compare airway function
in term babies of appropriate birth weight with those born small for
gestational age. As such, babies born small for gestational age were by
design over-represented in the original cohort. To create a sample
that would be representative of the normal population, that is, one in
which only 10% of infants would have birth weights less than or equal
to the 10th centile for gestational age, all but 13 of the original 54 small
for gestational age London term infants (four of whom had been tested
on two occasions) were randomly excluded.
Background characteristics of the remaining 459 infants (654 test occasions) who formed the representative population are summarized in Table 1, with infant characteristics at the time of first test summarized in Table 3. Weight and crown-heel length at time of test were converted to z scores, correcting for prematurity, by use of age after the expected rather than actual delivery date, where appropriate (45).
|
Statistical Analysis
The prediction equations were developed using all the available data,
including repeated measures for many infants. The smallest interval
between repeat measurements in any one child was 8 weeks, with a
mean (SD) of 23 (8) weeks between repeat measurements. Multiple
regression analysis was used to develop prediction equations, adjusting for the repeated measures by using generalized estimating equations assuming an exchangeable correlation matrix. The two sexes
were analyzed separately as equations combining them required significant sex interactions with age or length (p < 0.01). To adjust for
heteroscedasticity, the outcome measure of
maxFRC was transformed to its square root. This transformation was identified graphically to minimize both skewness and heteroscedasticity. The square
root transformation achieved this for both sexes. (
maxFRC)0.5 was
adjusted for body size in two ways: using length (Model 1; Table 4),
and using age plus length z score (Model 2; Table 4). Developing both
equations allows for situations in which the child's size is thought to
be more relevant than their age. Fractional polynomials of age and
length were used to adjust for curvature (46), and dummy variables
for center, ethnicity, and/or prematurity effects were added as required. Residuals were checked for normality and homoscedasticity.
|
Individual values of
maxFRC were converted to z scores (a z score
being the number of standard deviations by which a value deviates
from the mean), adjusting for age and/or length (and other variables)
using the formula z score = ([
maxFRC]0.5
LP)/RSD, where
maxFRC
is the infant's measurement (i.e., mean
maxFRC), LP is the linear
predictor for the child's sex, age, and length (and other variables), and
RSD is the residual standard deviation of (
maxFRC)0.5. Analyses
were done with Stata 6.0 (Stata, College Station, TX) and Data Desk
6.1.1 (Data Description, Ithaca, NY).
| |
RESULTS |
|---|
|
|
|---|
Scatter plots with infants identified by test center demonstrated a positive relationship between mean
maxFRC and
both age (Figure 1) and length (Figure 2). A scatter plot distinguishing infants by sex (data not shown) suggested that the
relationship between
maxFRC and length differed by sex,
with flows being lower in boys than girls during early infancy
but subsequently increasing more rapidly. This was confirmed
by the presence of significant interactions of sex with age or
length (p < 0.01) in both univariate and multivariate models.
For reference equations relating (
maxFRC)0.5 to length, the
optimal powers were length for girls and length2 for boys. After
adjusting for length, (
maxFRC)0.5 variance was not further explained by adding age to the model. For the prediction equations using age and length z score, age itself was optimal for
boys whereas the square root of age was optimal for girls, with
10 weeks added to age to deal with the negative corrected
postnatal ages in those tested before 40 weeks postconceptional age. Length z score was added to both age models even
though it was not significant for boys.
|
|
Table 4 gives details of the four regression equations. The
regressions and generalized estimating equation analyses gave similar results and those based on an exchangeable correlation matrix, which took into account any association between repeated measures, are presented. With the exception of length z
score for boys, all the coefficients were highly significant. Each
equation accounted for about half the variation in
maxFRC,
with the age model slightly better for boys and the length model
slightly better for girls. The equations for the two sexes were
quite different, with more curvature in boys for both age and
length as shown by the differing transformations. These differences are summarized in Tables 5 and 6, which show predicted
values for boys and girls at specified lengths and ages. It can be
seen that mean
maxFRC remains higher in girls to at least 75 cm when based on length, and 12 months when predicted on
age. Figure 3 shows
maxFRC predicted by length for
2, 0, and
+2 z scores in boys and girls. These correspond roughly to the
2nd, 50th, and 98th centiles. The skewness in the centiles is apparent, with the curves closer together below the median than
above it. Figure 4 shows the effect of length when predicted values of
maxFRC are based on age in girls. The three sets of
curves represent predictions by age of
2, 0, and +2 z scores
for
maxFRC, and within each cluster the three curves are for
2, 0, and +2 length z scores, to take into account girls who are
long or short for their age. The effect of length on age-predicted
values of
maxFRC is far smaller in boys as reflected by the nonsignificant length coefficient (Model 2; Table 4).
|
|
|
|
Within each center, the mean z score of
maxFRC was close
to 0 (1) when using either the length- or age-based equations, suggesting that there were no important differences either between preterm and term infants or between centers (Table E1;
see online data supplement). The effect of prematurity was further investigated by fitting a dummy variable just for the London
preterm group. In no case was the effect significant (p > 0.15),
showing that after adjustment for age and length,
maxFRC in
the preterm infants was close to prediction. Omitting the preterm data entirely from the model led to the same conclusion.
Ethnicity effects were tested for by using dummy variables for
black subjects and Hispanic subjects, with white subjects as
the baseline. Neither variable was significant in boys but black
girls had significantly greater
maxFRC than white girls (+0.65
z score adjusted for height, p = 0.02; +0.60 z score adjusted
for age, p = 0.02).
| |
DISCUSSION |
|---|
|
|
|---|
In this investigation, we have presented sex-specific prediction
equations for
maxFRC during the first 20 months of life. By
combining data from three centers, these prediction equations are based on a larger sample than reported previously and are relatively evenly distributed throughout the first 20 months of life. They are thus likely to provide more robust estimates of normal peripheral airway function during infancy than have
been available in the past.
Sex Differences in Airway Function
These results strongly support previous evidence that length-adjusted
maxFRC is significantly higher in girls than boys during the first year of life. Airway structure has been shown to
differ in male and female infants, and it has been suggested that the greater amount of smooth muscle and thicker inner airway wall in boys may provide part of the explanation for sex
differences in airway function and susceptibility to respiratory
disease in early life (47). The observed sex differences in flow
may also be attributed to differences in airway tone (48) and/or
lung mechanical properties (49) between boys and girls.
The magnitude of this sex difference was greatest during
the first 9 months of life (approximately 20% in infants 50 to
70 cm in length), and decreased with advancing age (Table 6).
Although several studies have reported that boys have lower
maxFRC values than girls (9, 37, 38, 40), others have observed
only a trend (14) or no significant difference. These discrepancies may well be related to relatively small sample size in some
of the studies and/or the age distribution of subjects. The current data further demonstrate that the rate of increase in
maxFRC, which presumably reflects airway growth, proceeds
more slowly in boys than in girls from birth to 6-9 months of
age, then accelerates faster in boys than in girls, so that when
predicted on the basis of age, flows are similar by 15 months
and 10% greater in boys by 18 months (Table 6). However,
when based on length,
maxFRC remained higher in girls until
at least 75 cm (Figure 3), beyond which length relatively small
numbers and wide confidence intervals limit interpretation of
potential sex differences. More recently, when using the raised
volume rapid thoracoabdominal compression technique, Jones
and coworkers (5) reported significantly lower FEF75% values
(forced expiratory flow rate when 75% of the vital capacity
has been expired) for boys than for girls up to 100 cm in length
and 34 months of age. Pulmonary function results from 8- to
15-year-old children have suggested different growth patterns of airways and parenchyma during childhood and adolescence
(50). In boys, lung growth appears to be proportional to growth
of the small airways whereas in girls, the small airways grow
faster than lung volume such that, in contrast to boys, FEF50%
and FEF75% corrected for total lung capacity (TLC) are positively correlated to body height in girls (50). Similarly, values
of lung size-corrected
maxFRC have been found to be significantly higher for 4- to 6-year-old girls than for boys (51). These
observed differences in small airway and lung growth between
the sexes may contribute to the higher prevalence and severity
of lower respiratory tract illness in boys during infancy and
childhood. Sex differences in lung size-corrected airway function appear to persist into adulthood, with women having
higher values of FEV1/FVC than men (52). Regrettably, it was
not feasible to examine sex-specific lung size-corrected forced
expiratory flows in this current analysis, because lung volumes
were not routinely measured in all the studies. In addition, it is
extremely difficult to measure resting lung volume simultaneously with forced expired flow in infants. The variability of
the end-expiratory level in infants and the differences in measured values of lung volume according to the technique used (53)
further complicate expression and interpretation of "volume-corrected flows" during infancy. Nevertheless, the current analysis provides clear evidence of sex differences in
maxFRC that
must be accounted for when interpreting results.
It is important to stress that prediction equations in this
study represent the cross-sectional, not longitudinal, relationship between
maxFRC and other variables (40, 54). This may
be problematic for clinicians who wish to monitor change over
time in individual patients as, to date, longitudinal data are lacking and will be difficult to obtain. Models based on longitudinal data are unlikely to change the predicted mean and z
scores, but may help quantify the extent of centile crossing observed in healthy infants and hence serve to identify individuals
with a significant decline or improvement in airway function.
In this study, modeling was performed using the mean of the
three highest technically acceptable
maxFRC values. In contrast to the rationale for reporting the "highest" values of forced flows
and volumes in conventional spirometry or when using the raised
volume technique, we recommend reporting the mean of the best
three
maxFRC values, because the highest may simply reflect a
temporary increase in the extent to which end-expiratory level is
being dynamically elevated. The relationship between mean
and best
maxFRC was investigated on the basis of the London
data, for which both were available, and found to be as follows:
best
maxFRC = 1.07 × mean
maxFRC (r2 = 0.99). (Additional
details are available in the online data supplement.)
Choice of Predictor
In this study, body size and age were found to be equally powerful predictors of peripheral airway function, accounting for about half the variance across the age range studied. In physiological terms this makes sense as lung growth is related to
growth in length, which is in turn related to age. Length and age
are highly correlated but age has the potential advantage over
length of being less prone to measurement error and less dependent on socioeconomic status. Nevertheless, if age is to be
used as the primary predictor of
maxFRC, it is essential that
gestational age be recorded accurately and any prematurity
corrected for by adjusting estimates of postnatal age for expected rather than actual date of delivery, especially in the first
few months of life.
In clinical settings, reference data may be used to interpret individual measurements in infants with lung disease such as cystic fibrosis or congenital heart disease. As such infants may be short and light for their age, use of reference data modeled primarily on age, which assumes normal growth patterns, may mean that the predicted values far exceed those that could be reasonably expected for such a child. In these circumstances, the clinician may wish to report values predicted from length, hence the reason for reporting both in this article.
Issues and Limitations in the Presentation of Normative Reference Values
These collated data represent the largest multicenter study of
maxFRC in healthy infants. Nonetheless, several issues could impact on the generalizability of these findings and therefore demand that these data continue to be interpreted and applied with caution. Moreover, the difficulties in recruiting and completing these tests with healthy infants makes the number of
observations even in this "large" data set far smaller than those
serving as reference standards for lung function in adults.
Center Differences
Although there was no evidence of any significant "center" influence on the results presented (Table E1; see online data supplement), differences in population, equipment and methods, and recruitment procedure will inevitably occur in any multicenter study. Thus, whereas the London and Indianapolis studies were conducted in well-equipped infant pulmonary function laboratories within university tertiary care pediatric hospitals, the Boston infant laboratory was specifically set up in 1986 in an urban community outpatient health center for the purpose of the study (38). Similarly, although development of commercially available equipment that meets American Thoracic Society/European Respiratory Society specifications (36) means that identical equipment will be available for future multicenter studies, this was not the case previously. Nevertheless, data collated for this study were collected from three centers using similar methods, equipment, and criteria for quality control as ascertained by interlaboratory visits. Reassuringly, despite some inevitable differences both in populations recruited and methods used, comparison of z scores between the different centers revealed no important differences (Table E1; see online data supplement).
Participation/Selection Bias
A potential source of bias that could influence the generalizability of these data would be that parents of infants who participated in this study had some real or perceived concern about the respiratory health of their infant. Recruitment prenatally in the Boston study and shortly after birth in the London and Indianapolis studies diminished the likelihood that this was an important or likely influence. Similarly, although concern over existing familial respiratory conditions could have influenced parental decisions, reports from studies that have compared the characteristics of parents who do or do not give consent for testing suggest that this may not be a major factor determining parental participation (55).
Normal Infants and Lung Function Reference Data: Inclusion Criteria
The purpose of this investigation was to provide normative
sex-specific reference data for
maxFRC during the first 20 months of life. One important issue is to define what constitutes a "normal" infant. For infants with known chronic pulmonary conditions such as cystic fibrosis or bronchopulmonary
dysplasia, exclusion justification is readily apparent. However,
in the case of infants with chronic conditions that are not
known to impact on pulmonary function, these decisions are
not so straightforward. Similarly, whereas infants born to
mothers who smoke during pregnancy are generally "normal,"
several studies have suggested that their pulmonary function
may be adversely influenced by this exposure (9, 13, 31, 55, 56).
In the current investigation, ~ 30% of the "healthy" infants
were born to mothers who smoked during pregnancy, which is
consistent with that reported for antenatal populations (57-59).
The influence of smoking on airway function is the subject of a
separate report (60).
Prior Respiratory Illness
Diminished airway function has been reported to precede and follow lower respiratory tract illness (LRI) in infancy (11, 40, 61). Infants with LRI before the first test were excluded from all studies, but this is unlikely to have produced any population bias, especially as infants included in this investigation were not selected according to recognized risk factors for LRI such as family history of atopy or maternal smoking (40, 55). Whether infants who had been affected by an LRI should be excluded from reference pulmonary function data once completely recovered remains debatable. Guiding our decisions with respect to this issue was an attempt to include common conditions that are widely represented in the general population, so that the reference standards developed would represent part of the broad spectrum of "normal." Thus, whereas infants with known chronic cardiopulmonary conditions were excluded, neither exposure to environmental tobacco smoke (an experience shared by up to 50% of children) (62, 63) nor an LRI after the first test occasion (up to 30% of infants wheeze in the first year of life) (55, 61) was a reason for exclusion from this study. All infants were, however, required to be free of any respiratory symptoms for at least 1 week (3 weeks in London and Indianapolis) before testing was undertaken. Use of the less stringent criteria in Boston did not appear to introduce any systematic bias, but needs further validation before it could be recommended, as discussed in the online data supplement.
Prematurity
The decision to include data from otherwise "healthy" preterm infants in the current investigation was based on examination of (1) scatter plots of the preterm
maxFRC data, which
showed a similar relationship to both age and length as in normal term and older infants, and (2) prediction equations formulated without the preterm infant data, which demonstrated
no substantial differences from those with these infants included (Table E1; see online data supplement). We therefore
consider these reference standards appropriate for use in preterm infants who fall within the gestational and postconceptional age range of the population reported here (i.e., 29
36
weeks gestational age, and 32
41 weeks postconceptional age) provided that postnatal age is adjusted for expected
rather than actual date of birth. Whether this is also true for
preterm infants studied during later infancy has yet to be ascertained, because premature delivery could have an adverse
effect on subsequent airway growth (64, 65).
Ethnic Group
Potential ethnic influences on the prediction equations were evaluated by repeat analyses with separate terms for Hispanic and black infants. These two terms failed to show differences by ethnic group for male infants, whereas higher flows (~ +0.6 z score) were observed for black versus white infant girls when adjusted for age and height. This result should be viewed as preliminary, as the majority of black girls were studied during the first few weeks of life (Table 3), when ethnic differences in lung maturation and breathing pattern may influence the extent to which lung volume is dynamically elevated (10). Ethnic representation in the current investigation was inadequate to allow a comprehensive analysis of the possible impact of ethnic differences on infant airway growth, and it is therefore inappropriate to publish separate regression equations at this time. This underscores the need to continue recruiting and studying airway function in normal infants, and to document not only sex, age, and body size but any other potentially important influences such as ethnicity, history of respiratory illness, environmental exposures, and family history of lung disease.
Comparison with Previously Published Data
Although there have been several attempts to report normative data for
maxFRC (14, 38-40), the use of currently available prediction equations could lead to different interpretation of results, as summarized in Tables 7 and 8.
|
|
As can be seen, whether based on length or age, much
lower predicted values were published from early applications
of this technique in Tucson (37) (on which were also subsequently based the collated data of Hampton and coworkers
[39]). This has been attributed at least partially to failure to
achieve flow limitation in every infant during some of the pioneering work. The reason for similarly low values in data published from Perth, Australia (40) is less easily explained, and
emphasizes the difficulties in using reference data developed
in different laboratories. Thus, whereas Young and coworkers
(40) also reported significantly lower
maxFRC in boys than in
girls, flows in both sexes were 15
25% lower than those reported in either the independent Indianapolis and Boston
studies (14, 38) or the currently collated populations. As mentioned above, there were no important center differences observed in this study and any discrepancies in predicted values between the current and "original" equations published by
Tepper and Reister (14) and Hanrahan and coworkers (38)
primarily reflect the different age distribution of infants,
which is much more evenly balanced in the collated data set.
Furthermore, neither Hanrahan and coworkers nor Tepper
and Reister presented sex-specific equations. This could preclude detection of clinically significant changes in girls, and
lead to false reports of impaired airway function in boys. The
current analysis has two further advantages: First, the data
have been presented as z scores, which provide a true indication of the natural variability among healthy infants. As can be
seen from Figure 3 and Tables 5 and 6, the wide range of
maxFRC values during early life among "normal" infants limits the extent to which any young infant can be labeled as "abnormal" with respect to such flows. Appropriate use of z
scores, which indicate a "normal" range (0 ± 2 z scores) for
maxFRC during infancy should improve interpretation of
both clinical and research studies. Second, by extending the
range of age and length to these prediction equations by including preterm infants, more reliable estimates of the immediate effects of neonatal lung disease should be possible. Extrapolation of any of the previously available equations
(which should be strongly discouraged) would have resulted in
marked underestimation of expected flows at time of discharge from the neonatal unit (Table 7).
| |
FUTURE DIRECTIONS |
|---|
|
|
|---|
It is possible that other techniques for measuring forced expiration in infants will supplant
maxFRC as a measure of airway function in the future. Indeed, several centers are now using raised volume forced expiratory maneuvers. This technique
has the theoretic appeal of sampling flows across the entire
volume range and is thus more akin to a fuller voluntary
forced expiratory maneuver in adults, a well-established standard for decades. Nonetheless, normative standards for any
new technique will need to be developed before it can replace
maxFRC, as will a body of clinical and epidemiological data to
match that currently available for
maxFRC, and which has
made it such a useful measure of the influence of environmental exposures, subsequent respiratory symptoms, or illness.
Conclusion
In conclusion, we have presented data on
maxFRC from a
combined cohort of 459 infants and 654 test sessions, and have
established sex-specific prediction equations for this measure
in the first 20 months of life. We conclude that normal infant
girls have higher flows up to at least 12 months of age and 75 cm
in length. The observed sex differences in flows during infancy
may reflect differences in airway structure and tone, and rate
of growth of the peripheral airways and lung parenchyma between boys and girls. These differences appear to persist in
childhood and adolescence.
This study underscores the need for all infant lung function centers to embrace consensus standard methodologies and for multicenter data sharing. In addition, it emphasizes the importance of thorough, standardized characterization of demographic features, environmental exposures, illness, and family history of all infants undergoing tests. Only by careful scrutiny of all factors that could impact on airway growth, and a willingness on the part of investigators to share and combine data to enable studies with adequate power to address these issues, can a clearer understanding of the influences on infant lung function emerge.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Ms. Ah-Fong Hoo, Portex Anaesthesia, Intensive Therapy and Respiratory Medicine Unit, Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, 30 Guilford Street, London WC1N 1EH, UK. E-mail: a.hoo{at}ich.ucl.ac.uk
(Received in original form March 8, 2001 and accepted in revised form January 9, 2002).
This article has an online data supplement, which is accessible from this issue's table of contents online at www.atsjournals.orgAcknowledgments: The authors gratefully acknowledge the assistance of Robert Castile, Frank Speizer, Ira Tager, Matthias Henschen, Sooky Lum, Iris Goetz, Rosie Castle, and Sarath Ranganathan in data collection and analysis.
Supported by the Dunhill Medical Trust, the Foundation for the Study of Infant Deaths, and Portex Plc. (A-F. H., J. S.). Research at the Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust benefits from R&D funding received from the NHS Executives; supported by grant HL-RO1 36474, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health (J. P. H.); supported by grant RO1 HL 54062, National Heart, Lung, and Blood Institute, National Institutes of Health (R. S. T.).
| |
References |
|---|
|
|
|---|
1.
Allen J,
Gappa M.
The raised volume rapid thoracoabdominal compression
technique. The Joint American Thoracic Society/European Respiratory
Society Working Group on Infant Lung Function.
Am J Respir Crit
Care Med
2000;
161:
1760-1762
2.
Feher A,
Castile R,
Kisling J,
Angelicchio C,
Filbrun D,
Flucke R,
Tepper R.
Flow limitation in normal infants: a new method for forced expiratory maneuvers from raised lung volumes.
J Appl Physiol
1996;
80:
2019-2025
3. Turner DJ, Stick SM, Le Souëf KL, Sly PD, Le Souëf PN. A new technique to generate and assess forced expiration from raised lung volume in infants. Am J Respir Crit Care Med 1995; 151: 1441-1450 [Abstract].
4. Le Souëf PN, Castile R, Motoyama E, Turner D, Morgan W. Forced expiratory maneuvers. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, editors. Infant respiratory function testing. New York: John Wiley & Sons; 1996. p. 379-410.
5.
Jones M,
Castile R,
Davis S,
Kisling J,
Filbrun D,
Flucke R,
Goldstein A,
Emsley C,
Ambrosius W,
Tepper RS.
Forced expiratory flows and volumes in infants.
Am J Respir Crit Care Med
2000;
161:
353-359
6.
Taussig LM,
Landau LI,
Godfrey S,
Arad I.
Determinants of forced expiratory flows in newborn infants.
J Appl Physiol
1982;
53:
1220-1227
7. Turner DJ, Morgan SEG, Landau LI, Le Souëf PN. Methodological aspects of flow-volume studies in infants. Pediatr Pulmonol 1990; 8: 289-293 [Medline].
8. Tepper RS, Eigen H, Brown J, Hurwitz R. Use of maximal expiratory flows to evaluate central airways obstruction in infants. Pediatr Pulmonol 1989; 6: 272-274 [Medline].
9.
Hoo A-F,
Henschen M,
Dezateux C,
Costeloe K,
Stocks J.
Respiratory
function among preterm infants whose mothers smoked during pregnancy.
Am J Respir Crit Care Med
1998;
158:
700-705
10.
Stocks J,
Henschen M,
Hoo A-F,
Costeloe K,
Dezateux CA.
The influence of ethnicity and gender on airway function in preterm infants.
Am J Respir Crit Care Med
1997;
156:
1855-1862
11. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM, Group Health Medical Associates' Personnel. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988;319:1112-1117.
12. Young S, Le Souëf PN, Geelhoed GC, Stick SM, Turner KJ, Landau LI. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991; 324: 1168-1173 [Abstract].
13. Hanrahan JP, Tager IB, Segal MR, Tosteson TD, Castile RG, Van VH, Weiss ST, Speizer FE. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis 1992;145:1129-1135.
14. Tepper RS, Reister T. Forced expiratory flows and lung volumes in normal infants. Pediatr Pulmonol 1993; 15: 357-361 [Medline].
15.
Prendiville A,
Green S,
Silverman M.
Airway responsiveness in wheezy
infants: evidence for functional
adrenergic receptors.
Thorax
1987;
42:
100-104
16. Maayan C, Itzhatki T, Bar-Yishay E, Gross S, Tal A, Godfrey S. The functional response of infants with persistent wheezing to nebulised beclomethosone diproprionate. Pediatr Pulmonol 1986; 2: 9-14 [Medline].
17. Geller DE, Morgan WJ, Cota KA, Wright AL, Taussig LM. Airway responsiveness to cold, dry air in normal infants. Pediatr Pulmonol 1988; 4: 90-97 [Medline].
18. Hiatt P, Eigen H, Yu P, Tepper RS. Bronchodilator responsiveness in infants and young children with cystic fibrosis. Am Rev Respir Dis 1988; 137: 119-122 [Medline].
19. Tepper RS, Rosenberg D, Eigen H, Reister T. Bronchodilator responsiveness in infants with bronchiolitis. Pediatr Pulmonol 1994; 17: 81-85 [Medline].
20. Benoist MR, Brouard JJ, Rufin P, Delacourt C, Waernessyckle S, Scheinmann P. Ability of new lung function tests to assess metacholine-induced airway obstruction in infants. Pediatr Pulmonol 1994; 18: 308-316 [Medline].
21. Tepper RS, Montgomery GL, Ackerman V, Eigen H. Longitudinal evaluation of pulmonary function in infants and very young children with cystic fibrosis. Pediatr Pulmonol 1993; 16: 96-100 [Medline].
22.
Beardsmore CS,
Thompson JR,
Williams A,
McArdle EK,
Gregory GA,
Weaver LT,
Simpson H.
Pulmonary function in infants with cystic fibrosis: the effect of antibiotic treatment.
Arch Dis Child
1994;
71:
133-137
23. Tepper RS, Hiatt P, Eigen H, Scott P, Grosfeld J, Cohen M. Infants with cystic fibrosis: pulmonary function at diagnosis. Pediatr Pulmonol 1988; 5: 15-18 [Medline].
24. Mallory GBJ, Motoyama EK, Koumbourlis AC, Mutich RL, Nakayama DK. Bronchial reactivity in infants in acute respiratory failure with viral bronchiolitis. Pediatr Pulmonol 1989; 6: 253-259 [Medline].
25. Tepper RS, Rosenberg D, Eigen H. Airway responsiveness in infants following bronchiolitis. Pediatr Pulmonol 1992; 13: 6-10 [Medline].
26. Baraldi E, Filippone M, Trevisanuto D, Zanardo V, Zacchello F. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997; 155: 149-155 [Abstract].
27. Abbasi S, Bhutani VK, Gerdes JS. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant. J Pediatr 1993; 122: 446-452 [Medline].
28.
Beardsmore C,
Dundas I,
Poole K,
Enock K,
Stocks J.
Respiratory function in survivors of the UK Extracorporeal Membrane Oxygenation
Trial.
Am J Respir Crit Care Med
2000;
161:
1129-1135
29. Greenspan JS, Antunes MJ, Holt WJ, McElwee D, Cullen JA, Spitzer AR. Pulmonary sequelae in infants treated with extracorporeal membrane oxygenation. Pediatr Pulmonol 1997; 23: 31-38 [Medline].
30.
Thomson AH,
Beardsmore CS,
Firmin R,
Leanage R,
Simpson H.
Airway function in infants with vascular rings: preoperative and postoperative assessment.
Arch Dis Child
1990;
65:
171-174
31. Tager IB, Hanrahan JP, Tosteson TD, Castile RG, Brown RW, Weiss ST, Speizer FE. Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Respir Dis 1993; 147: 811-817 [Medline].
32. Clarke JR, Salmon B, Silverman M. Bronchial responsiveness in the neonatal period as a risk factor for wheezing in infancy. Am J Respir Crit Care Med 1995; 151: 1434-1440 [Abstract].
33. Young S, Arnott J, Le Souëf PN, Landau LI. Flow limitation during tidal expiration in symptom-free infants and the subsequent development of asthma. J Pediatr 1994; 124: 681-688 [Medline].
34. Young S, Arnott J, O'Keeffe PT, Le Souëf PN, Landau LI. The association between early life lung function and wheezing during the first 2 years of life. Eur Respir J 2000; 15: 151-157 [Abstract].
35. Frey U, Stocks J, Coates A, Sly P, Bates J. Standards for infant respiratory function testing: specifications for equipment used for infant pulmonary function testing. Eur Respir J 2000; 16: 731-740 [Abstract].
36. Stocks J, Sly PD, Morris MG, Frey U. Standards for infant respiratory function testing: what(ever) next? Eur Respir J 2000; 16: 581-584 [Medline].
37. Tepper RS, Morgan WJ, Cota K, Wright A, Taussig LM, Group Health Medical Associates' Pediatricians. Physiologic growth and development of the lung during the first year of life. Am Rev Respir Dis 1986;134: 513-519.
38. Hanrahan JP, Tager IB, Castile RG, Segal MR, Weiss ST, Speizer FE. Pulmonary function measures in healthy infants: variability and size correction. Am Rev Respir Dis 1990; 141: 1127-1135 [Medline].
39. Hampton F, Beardsmore CS, Morgan W, Williams A, Taussig L, Thompson JR. A scoring system for lung function tests in infants. Pediatr Pulmonol 1992; 14: 149-155 [Medline].
40. Young S, Sherrill DL, Arnott J, Diepeveen D, LeSouëf PN, Landau LI. Parental factors affecting respiratory function during the first year of life. Pediatr Pulmonol 2000; 29: 331-340 [Medline].
41.
Dezateux C,
Stocks J.
Lung development and early origins of childhood
respiratory illness.
Br Med Bull
1997;
53:
40-57
42. Dezateux CA, Wade AM, Schmalisch G, Landau L. Maximizing effective research in infant respiratory function. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, editors. Infant respiratory function testing. New York: John Wiley & Sons; 1996. p. 521-550.
43. Sly P, Tepper R, Henschen M, Gappa M, Stocks J. Standards for infant respiratory function testing: tidal forced expirations. Eur Respir J 2000; 16: 741-748 [Abstract].
44.
Lum S,
Hoo A-F,
Dezateux CA,
Goetz I,
Wade AM,
DeRooy L,
Costeloe K,
Stocks J.
The association between birthweight, sex and airway
function in infants of non-smoking mothers.
Am J Respir Crit Care
Med
2001;
164:
2078-2084
45.
Freeman JV,
Cole TJ,
Chinn S,
Jones PRM,
White EM,
Preece MA.
Cross sectional stature and weight reference curves for the UK, 1990.
Arch Dis Child
1995;
73:
17-24
46. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling (with discussion). Appl Stat 1994; 43: 429-467 .
47. McKay KO. Gender differences in airway wall structure in infant lungs. Am J Respir Crit Care Med 2000; 161: A111 .
48. Landau LI, Morgan W, McCoy KS, Taussig LM. Gender related differences in airway tone in children. Pediatr Pulmonol 1993; 16: 31-35 [Medline].
49. Taussig LM, Cota K, Kaltenborn W. Different mechanical properties of the lung in boys and girls. Am Rev Respir Dis 1981; 123: 640-643 [Medline].
50.
Pagtakhan RD,
Bjelland JC,
Landau LI,
Loughlin G,
Kaltenborn W,
Seeley G,
Taussig LM.
Sex differences in growth patterns of the airways and
lung parenchyma in children.
J Appl Physiol
1984;
56:
1204-1210
51. Taussig LM. Maximal expiratory flows at functional residual capacity: a test of lung function for young children. Am Rev Respir Dis 1977; 116: 1031-1038 [Medline].
52.
Becklake MR,
Kauffmann F.
Gender differences in airway behaviour
over the human life span.
Thorax
1999;
54:
1119-1138
53. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity: ATS Workshop on lung volume measurements [Official Statement of the European Respiratory Society]. Eur Respir J 1995; 8: 492-506 [Medline].
54. Edwards LJ. Modern statistical techniques for the analysis of longitudinal data in biomedical research. Pediatr Pulmonol 2000; 30: 330-344 [Medline].
55.
Dezateux C,
Stocks J,
Dundas I,
Fletcher ME.
Impaired airway function
and wheezing in infancy: the influence of maternal smoking and a genetic
predisposition to asthma.
Am J Respir Crit Care Med
1999;
159:
403-410
56. Stick SM, Burton PR, Gurrin L, Sly PD, Le Souëf PN. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996; 348: 1060-1064 [Medline].
57.
Ebrahim SH,
Floyd RL,
Merritt RK,
Decoufle P,
Holtzman D.
Trends in
pregnancy-related smoking rates in the United States, 1987-1996.
JAMA
2000;
283:
361-366
58.
Owen L,
McNeill A,
Callum C.
Trends in smoking during pregnancy in
England, 1992-7: quota sampling surveys.
Br Med J
1998;
317:
728-730
59. Owen L, Penn G. Smoking in pregnancy: a survey of knowledge, attitudes and behaviors, 1992 to 1999. London: Health Education Authority; 1999.
60. Dezateux C, Hoo A-F, Cole TJ, Stocks J, Hanrahan J. Influence of maternal smoking on peripheral airway function during the first 18 months of life. Thorax 2000; 55: A9 .
61.
Dezateux C,
Stocks J,
Wade AM,
Dundas I,
Fletcher ME.
Airway function at one year: association with premorbid airway function, wheezing and maternal smoking.
Thorax
2001;
56:
680-686
62.
Cook DG,
Strachan DP.
Summary of effects of parental smoking on the
respiratory health of children and implications for research.
Thorax
1999;
54:
357-366
63.
Jarvis MJ,
Goddard E,
Higgins V,
Feyerabend C,
Bryant A,
Cook DG.
Children's exposure to passive smoking in England since the 1980s:
cotinine evidence from population surveys.
Br Med J
2000;
321:
343-345
64. Coates AL, Bergsteinsson H, Desmond K, Outerbridge EW, Beaudry PH. Long-term pulmonary sequelae of premature birth with and without idiopathic respiratory distress syndrome. J Pediatr 1977; 90: 611-616 [Medline].
65. Mansell AL, Driscoll JM, James LS. Pulmonary follow-up of moderately low birthweight infants with and without respiratory distress syndrome. J Pediatr 1987; 110: 111-115 [Medline].
This article has been cited by other articles:
![]() |
B. S. von Ungern-Sternberg, D. Trachsel, T. O. Erb, and J. Hammer Forced expiratory flows and volumes in intubated and paralyzed infants and children: normative data up to 5 years of age J Appl Physiol, July 1, 2009; 107(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
L M Borrego, J Stocks, P Leiria-Pinto, I Peralta, A M Romeira, N Neuparth, J E Rosado-Pinto, and A-F Hoo Lung function and clinical risk factors for asthma in infants and young children with recurrent wheeze Thorax, March 1, 2009; 64(3): 203 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Friedrich, P. M. C. Pitrez, R. T. Stein, M. Goldani, R. Tepper, and M. H. Jones Growth Rate of Lung Function in Healthy Preterm Infants Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1269 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kotaniemi-Syrjanen, L. P. Malmberg, A. S. Pelkonen, K. Malmstrom, and M. J. Makela Airway responsiveness: associated features in infants with recurrent respiratory symptoms Eur. Respir. J., December 1, 2007; 30(6): 1150 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mahut, J. De Blic, S. Emond, M.-R. Benoist, P.-H. Jarreau, T. Lacaze-Masmonteil, J.-F. Magny, and C. Delacourt Chest computed tomography findings in bronchopulmonary dysplasia and correlation with lung function Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2007; 92(6): F459 - F464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Beardsmore, J. Westaway, H. Killer, R. K. Firmin, and H. Pandya How Does the Changing Profile of Infants Who Are Referred for Extracorporeal Membrane Oxygenation Affect Their Overall Respiratory Outcome? Pediatrics, October 1, 2007; 120(4): e762 - e768. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Davis, A. S. Brody, M. J. Emond, L. C. Brumback, and M. Rosenfeld Endpoints for Clinical Trials in Young Children with Cystic Fibrosis Proceedings of the ATS, August 1, 2007; 4(4): 418 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Beydon, S. D. Davis, E. Lombardi, J. L. Allen, H. G. M. Arets, P. Aurora, H. Bisgaard, G. M. Davis, F. M. Ducharme, H. Eigen, et al. An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary Function Testing in Preschool Children Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1304 - 1345. [Full Text] [PDF] |
||||
![]() |
A J Colom, A M Teper, W M Vollmer, and G B Diette Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis Thorax, June 1, 2006; 61(6): 503 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Henschen, J. Stocks, I. Brookes, and U. Frey New aspects of airway mechanics in pre-term infants Eur. Respir. J., May 1, 2006; 27(5): 913 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Friedrich, R. T. Stein, P. M. C. Pitrez, A. L. Corso, and M. H. Jones Reduced Lung Function in Healthy Preterm Infants in the First Months of Life Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 442 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Teper, C. D. Kofman, and S. M. Vidaurreta Inhaled Corticosteroids in Wheezy Infants Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 1059 - 1059. [Full Text] [PDF] |
||||
![]() |
A. M. Teper, C. D. Kofman, G. A. Szulman, S. M. Vidaurreta, and A. F. Maffey Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 587 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hofhuis, E. C. van der Wiel, E. M. Nieuwhof, W. C. J. Hop, M. J. Affourtit, F. J. Smit, A. A. P. H. Vaessen-Verberne, F. G. A. Versteegh, J. C. de Jongste, P. J. F. M. Merkus, et al. Efficacy of Fluticasone Propionate on Lung Function and Symptoms in Wheezy Infants Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 328 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.J.L.E. Vrijlandt and J. Gerritsen The womb and lung function later in life Eur. Respir. J., November 1, 2004; 24(5): 722 - 723. [Full Text] [PDF] |
||||
![]() |
W. Hofhuis, J. C. de Jongste, P. J. F. M. Merkus, C. W. Bollen, C. S. P. M. Uiterwaal, and A. J. van Vught High-Frequency Ventilation in Premature Neonates Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 466 - 467. [Full Text] [PDF] |
||||
![]() |
R J P G Chavasse and P Seddon Response to salbutamol by wheezy infants Arch. Dis. Child., August 1, 2004; 89(8): 796 - 796. [Full Text] [PDF] |
||||
![]() |
J. Joseph-Bowen, N. H. de Klerk, M. J. Firth, G. E. Kendall, P. G. Holt, and P. D. Sly Lung Function, Bronchial Responsiveness, and Asthma in a Community Cohort of 6-Year-Old Children Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 850 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Dezateux, S Lum, A-F Hoo, J Hawdon, K Costeloe, and J Stocks Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis Thorax, January 1, 2004; 59(1): 60 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.M. Gustafsson, P. Aurora, and A. Lindblad Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis Eur. Respir. J., December 1, 2003; 22(6): 972 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hulskamp, A.-f. Hoo, H. Ljungberg, S. Lum, J. J. Pillow, and J. Stocks Progressive Decline in Plethysmographic Lung Volumes in Infants: Physiology or Technology? Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 1003 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Tobin The Role of a Journal in a Scientific Controversy Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 511 - 511. [Full Text] [PDF] |
||||
![]() |
M. Gappa, J. Stocks, P. Merkus, and A. H. Jobe Lung Growth and Development after Preterm Birth: Further Evidence Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 399 - 400. [Full Text] [PDF] |
||||
![]() |
P. Merkus, M. Gappa, A.-F. Hoo, J. Stocks, H. Pan, and T. J. Cole Standard deviation scores of maximal expiratory flow in infants Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 258 - 259. [Full Text] [PDF] |
||||
![]() |
E. Bar-Yishay, A.-F. Hoo, J. Stocks, T. Cole, C. Dezateux, R. Tepper, and S. Ranganathan Prediction of maximum flow at functional residual capacity in infants: Normal range Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 129 - 132. [Full Text] [PDF] |
||||
![]() |
M. J. Tobin Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 333 - 344. [Full Text] [PDF] |
||||
![]() |
S. C. Ranganathan, A. Bush, C. Dezateux, S. B. Carr, A.-F. Hoo, S. Lum, S. Madge, J. Price, J. Stroobant, A. Wade, et al. Relative Ability of Full and Partial Forced Expiratory Maneuvers to Identify Diminished Airway Function in Infants with Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 15, 2002; 166(10): 1350 - 1357. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |